Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
<p><strong>Background</strong> Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-aminoquinoline th...
Hlavní autoři: | Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Massachusetts Medical Society
2019
|
Podobné jednotky
-
Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
Autor: Llanos-Cuentas, A, a další
Vydáno: (2019) -
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
Autor: St Jean, PL, a další
Vydáno: (2020) -
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
Autor: Watson, JA, a další
Vydáno: (2022) -
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
Autor: Watson, JA, a další
Vydáno: (2024) -
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
Autor: Mark M Fukuda, a další
Vydáno: (2017-01-01)